Showing results (2911-2920 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|November 6, 2004
An NCIC CTG phase I/pharmacokinetic study of the matrix metalloproteinase and angiogenesis inhibitor BAY 12-9566 in combination with 5-fluorouracil/leucovorinR Goel, E Chouinard, D J Stewart, et al.
Investigational New Drugs|November 6, 2004
Phase II study of oral bis (aceto) ammine dichloro (cyclohexamine) platinum (IV) (JM-216, BMS-182751) given daily x 5 in hormone refractory prostate cancer (HRPC)Tahir Latif, Laura Wood, Cindy Connell, et al.
Investigational New Drugs|January 24, 2004
A phase I trial of daily oral 4'- N -benzoyl-staurosporine in combination with protracted continuous infusion 5-fluorouracil in patients with advanced solid malignanciesJoseph P Eder, Rocio Garcia-Carbonero, Jeffrey W Clark, et al.
Investigational New Drugs|January 24, 2004
Phase I trial of the polyamine analog N1,N14-diethylhomospermine (DEHSPM) in patients with advanced solid tumorsGeorge Wilding, David King, Kendra Tutsch, et al.
Investigational New Drugs|January 24, 2004
Phase II trial of intra-arterial chemotherapy using a novel lipophilic platinum derivative (SM-11355) in patients with hepatocellular carcinomaTakuji Okusaka, Shuichi Okada, Toshio Nakanishi, et al.
Investigational New Drugs|January 24, 2004
Phase II study of CI-958 in patients with hormone refractory prostate carcinomaJ Philip Kuebler, Timothy Moore, James Pritchard, et al.
Investigational New Drugs|January 7, 2004
Inhibition of cell growth, induction of apoptosis and mechanism of action of the novel platinum compound cis-diaminechloro-[2-(diethylamino) ethyl 4-amino-benzoate, N(4)]-chloride platinum (II) monohydrochloride monohydrateMaria A Mariggiò, Sergio Cafaggi, Massimo Ottone, et al.
Investigational New Drugs|January 7, 2004
Gemcitabine and cisplatin for patients with metastatic or recurrent esophageal carcinoma: a Southwest Oncology Group StudySusan G Urba, Kari Chansky, Peter J VanVeldhuizen, et al.
Investigational New Drugs|November 6, 2004
A phase II study of sabarubicin (MEN-10755) as second line therapy in patients with locally advanced or metastatic platinum/taxane resistant ovarian cancerFrancesco Caponigro, Pax Willemse, Roberto Sorio, et al.
Investigational New Drugs|March 4, 2005
Impact of taurolidin and octreotide on liver metastasis and lipid peroxidation after laparoscopy in chemical induced ductal pancreatic cancerMaik Kilian, Jan Ilga Gregor, Ina Heukamp, et al.
Pageof 372